Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

11 Jun 2025

Meeting with Giulia Del Brenna (Head of Unit Internal Market, Industry, Entrepreneurship and SMEs)

20 May 2025 · Discussing developments after the instalment of the new college of Commissioners, including the revision of the General Pharmaceutical Legislation, the Critical Medicines Act and the Biotech Act.

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

17 Apr 2025

Response to Critical Medicines Act

27 Feb 2025

Meeting with Stefano Cavedagna (Member of the European Parliament)

10 Sept 2024 · Introductory meeting - discussion about the next legislative proposals

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 of the European Parliament and of the Council, detailed procedural rules for the cooperation of the Member State Coordination Group on Health Technology Assessment and the Commission with the European Medicines Agency in the form of exchange of information as regards the joint clinical assessment of medicinal products and medical devices and in vitro diagnostic medical devices and as regards the joint scientific consultation on medicinal products and medical devices

24 Jul 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 of the European Parliament and of the Council as regards the management of conflicts of interest in the joint work of the Member State Coordination Group on Health Technology Assessment and its subgroups

26 Jun 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

2 Apr 2024

Meeting with Aldo Patriciello (Member of the European Parliament)

28 Nov 2023 · Pharma

Meeting with Nicola Danti (Member of the European Parliament) and A. Menarini Industrie Farmaceutiche Riunite s.r.l.

7 Nov 2023 · Posizione su revisione pacchetto farmaceutico

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

2 Nov 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

2 Nov 2023

Meeting with Nicola Danti (Member of the European Parliament)

26 Apr 2023 · Organizzazione evento a Bruxelles

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on packaging and packaging waste, amending Regulation (EU) 2019/1020 and Directive (EU) 2019/904, and repealing Directive 94/62/EC

24 Apr 2023

Meeting with Marco Piantini (Cabinet of Commissioner Paolo Gentiloni)

26 Jul 2022 · Meeting Farminustria's new President Mr Marcello Cattani and DG Enrica Giorgetti: short exchange about the latest economic effects of the pandemic and the EU response

Meeting with Paolo Gentiloni (Commissioner)

26 Jul 2022 · Meeting Farminustria's new President Mr Marcello Cattani and DG Enrica Giorgetti: short exchange about the latest economic effects of the pandemic and the EU response

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on fluorinated greenhouse gases, amending Directive (EU) 2019/1937 and repealing Regulation (EU) No 517/2014

29 Jun 2022

Response to Enhancing the coherence and effectiveness of compulsory licensing of patents in the EU, especially in crisis situations, including for export purposes to third countries

29 Apr 2022

Response to Proposal for a Regulation amending Regulations (EC) No 469/2009 and 1610/96 concerning supplementary protection certificates (SPCs) with a view to creating a unified granting procedure, and proposal for a Regulation creating a unitary SPC

4 Apr 2022

Response to Commission proposal for a Council Recommendation on strengthened One Health Actions against Antimicrobial Resistance

24 Mar 2022

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) No 851/2004 establishing a European Centre for disease prevention and control

2 Feb 2021

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

6 Jan 2021

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

6 Jul 2020